Anti-infection tissue engineering construct treating osteomyelitis in Rabbit Tibia

Tissue Engineering - Part A

Volumn 19, Issue 1-2, 2013, Pages 255-263

  Xing, Junchao ^a,b,c   Hou, Tianyong ^a,b,c   Luobu, Bianba ^a,b,c   Luo, Fei ^a,b,c   Chen, Qianbo ^a,b,c   Li, Zhiqiang ^a,b,c   Jin, Huiyong ^a,b,c   Xu, Jianzhong ^a,b,c  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Laboratory of Tissue Engineering in Chongqing City   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE BEADS; ANTI-INFECTION; ANTIBIOTIC RELEASE; BONE DEFECT; BONE DEFECT MODELS; BONE GRAFTING; BONE REPAIR; CONTROL GROUPS; DELIVERY SYSTEMS; FAILURE RATE; FIBRIN GELS; IN-VIVO; MESENCHYMAL STEM CELL; OSTEOGENESIS; OSTEOGENIC POTENTIAL; RABBIT TIBIA; RADIOGRAPHIC ASSESSMENT; TIBIAL METAPHYSIS; TISSUE-ENGINEERED CONSTRUCTS; VANCOMYCIN;

ANTIBIOTICS; BACTERIA; BONE; CELL CULTURE; DEFECTS; SYNCHROTRONS; TISSUE;

SCAFFOLDS (BIOLOGY);

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS;

ANTIINFECTIVE AGENT; FIBRIN; TISSUE SCAFFOLD; VANCOMYCIN;

ANIMAL; ARTICLE; BONE PROSTHESIS; DELAYED RELEASE FORMULATION; FRACTURE HEALING; MULTIMODALITY CANCER THERAPY; OSTEOMYELITIS; RABBIT; SYNTHESIS; TIBIA; TIBIA FRACTURE; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS; BONE SUBSTITUTES; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; FIBRIN; FRACTURE HEALING; OSTEOMYELITIS; RABBITS; TIBIA; TIBIAL FRACTURES; TISSUE SCAFFOLDS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84871278622     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0262     Document Type: Article

References (38)

1. Klenerman, L. A history of osteomyelitis from the Journal of Bone and Joint Surgery: 1948 to 2006. J Bone Joint Surg Br 89, 667, 2007.
2. El-Husseiny, M., Patel, S., MacFarlane, R.J., and Haddad, F.S. Biodegradable antibiotic delivery systems. J Bone Joint Surg Br 93, 151, 2011.
3. Ueng, S.W., Lee, M.S., Lin, S.S., Chan, E.C., and Liu, S.J. Development of a biodegradable alginate carrier system for antibiotics and bone cells. J Orthop Res 25, 62, 2007.
4. Anal, A.K., and Stevens, W.F. Chitosan-alginate multilayer beads for controlled release of ampicillin. Int J Pharm 290, 45, 2005.
5. Schnieders, J., Gbureck, U., Thull, R., and Kissel, T. Controlled release of gentamicin from calcium phosphatepoly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27, 4239, 2006.
6. Wang, X., Venkatraman, S.S., Boey, F.Y., Loo, J.S., and Tan, L.P. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials 27, 5588, 2006.
7. Stigter, M., Bezemer, J., de Groot, K., and Layrolle, P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 99, 127, 2004.
8. Hou, T., Li, Q., Luo, F., Xu, J., Xie, Z., Wu, X., and Zhu, C. Controlled dynamization to enhance reconstruction capacity of tissue-engineered bone in healing critically sized bone defects: An in vivo study in goats. Tissue Eng Part A 16, 201, 2010.
9. Xu, J.Z., Qin, H., Wang, X.Q., Zhou, Q., Luo, F., Hou, T.Y., and He, Q.Y. Repair of large segmental bone defects using bone marrow stromal cells with demineralized bone matrix. Orthop Surg 1, 34, 2009.
10. Wang, L., Fan, H., Zhang, Z.Y., Lou, A.J., Pei, G.X., Jiang, S., Mu, T.W., Qin, J.J., Chen, S.Y., and Jin, D. Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized beta-tricalcium phosphate scaffold and mesenchymal stem cells. Biomaterials 31, 9452, 2010.
11. Buchholz, H.W., and Engelbrecht, H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41, 511, 1970.
12. Ueng, S.W., Yuan, L.J., Lee, N., Lin, S.S., Chan, E.C., and Weng, J.H. In vivo study of biodegradable alginate antibiotic beads in rabbits. J Orthop Res 22, 592, 2004.
13. Xia, Y., Mei, F., Duan, Y., Gao, Y., Xiong, Z., Zhang, T., and Zhang, H. Bone tissue engineering using bone marrow stromal cells and an injectable sodium alginate/gelatin scaffold. J Biomed Mater Res A 100, 1044, 2012.
14. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., and Thom, D. Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett 32, 195, 1973.
15. Hou, T., Xu, J., Li, Q., Feng, J., and Zen, L. In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Tissue Eng Part A 14, 1173, 2008.
16. Zhang, X., Xie, C., Lin, A.S., Ito, H., Awad, H., Lieberman, J.R., Rubery, P.T., Schwarz, E.M., O'Keefe, R.J., and Guldberg, R.E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res 20, 2124, 2005.
17. Cook, S.D., Wolfe, M.W., Salkeld, S.L., and Rueger, D.C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77, 734, 1995.
18. Kneser, U., Schaefer, D.J., Polykandriotis, E., and Horch, R.E. Tissue engineering of bone: The reconstructive surgeon's point of view. J Cell Mol Med 10, 7, 2006.
19. Isogai, N., Landis, W.J., Mori, R., Gotoh, Y., Gerstenfeld, L.C., Upton, J., and Vacanti, J.P. Experimental use of fibrin glue to induce site-directed osteogenesis from cultured periosteal cells. Plast Reconstr Surg 105, 953, 2000.
20. Catelas, I., Sese, N., Wu, B.M., Dunn, J.C., Helgerson, S., and Tawil, B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 12, 2385, 2006.
21. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H.A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497, 2003.
22. Norden, C.W. Experimental osteomyelitis. I. A description of the model. J Infect Dis 122, 410, 1970.
23. Gerhart, T.N., Roux, R.D., Horowitz, G., Miller, R.L., Hanff, P., and Hayes, W.C. Antibiotic release from an experimental biodegradable bone cement. J Orthop Res 6, 585, 1988.
24. Kanellakopoulou, K., and Giamarellos-Bourboulis, E.J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59, 1223, 2000.
25. Scoles, P.V., and Aronoff, S.C. Antimicrobial therapy of childhood skeletal infections. J Bone Joint Surg Am 66, 1487, 1984.
26. Ueng, S.W., Lee, S.S., Lin, S.S., Chan, E.C., Hsu, B.R., and Chen, K.T. Biodegradable alginate antibiotic beads. Clin Orthop Relat Res 380, 250, 2000.
27. Cevher, E., Orhan, Z., Mulazimoglu, L., Sensoy, D., Alper, M., Yildiz, A., and Ozsoy, Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm 317, 127, 2006.
28. Templeman, D.C., Gulli, B., Tsukayama, D.T., and Gustilo, R.B. Update on the management of open fractures of the tibial shaft. Clin Orthop Relat Res 350, 18, 1998.
29. Watson, J.T., Anders, M., and Moed, B.R. Management strategies for bone loss in tibial shaft fractures. Clin Orthop Relat Res 315, 138,1995.
30. Bootle-Wilbraham, C.A., Tazzyman, S., Thompson, W.D., Stirk, C.M., and Lewis, C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269, 2001.
31. Wong, C., Inman, E., Spaethe, R., and Helgerson, S. Fibrinbased biomaterials to deliver human growth factors. Thromb Haemost 89, 573, 2003.
32. Xie, H., Yang, F., Deng, L., Luo, J., Qin, T., Li, X., Zhou, G.Q., and Yang, Z. The performance of a bone-derived scaffold material in the repair of critical bone defects in a rhesus monkey model. Biomaterials 28, 3314, 2007.
33. Muschler, G.F., Nakamoto, C., and Griffith, L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A, 1541, 2004.
34. Perka, C., Schultz, O., Spitzer, R.S., Lindenhayn, K., Burmester, G.R., and Sittinger, M. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 21, 1145, 2000.
35. Breen, A., O'Brien, T., and Pandit, A. Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev 15, 201, 2009.
36. Ho, W., Tawil, B., Dunn, J.C., and Wu, B.M. The behavior of human mesenchymal stem cells in 3D fibrin clots: Dependence on fibrinogen concentration and clot structure. Tissue Eng 12, 1587, 2006.
37. Duong, H., Wu, B., and Tawil, B. Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng Part A 15, 1865, 2009.
38. Davis, H.E., Miller, S.L., Case, E.M., and Leach, J.K. Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response. Acta Biomater 7, 691, 2011.